 |
|
Corporate
Officers
|
Richard
J. Freer, Ph.D. Chairman of the Board and COO
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three
other partners, Dr. Freer has served as Chairman of the Board
and as a Director of the Company. From 1975 until 1997, Dr. Freer
was employed in the Department of Pharmacology and Toxicology at Virginia
Commonwealth University, rising through the academic ranks to full
Professor. In addition, from 1988-1995, Dr. Freer was first Director
and then Chair of the Biomedical Engineering Program. Freer received
the Bachelor's degree in Biology/Chemistry from Marist College, Poughkeepsie,
NY, and the Doctoral degree from Columbia University in Pharmacology.
Dr. Freer is the co-author of more than 150 peer reviewed journal
articles and book chapters, in his area of research expertise, molecular
pharmacology, peptide receptors, and is a co-inventor of 2 US patents.
Dr. Freer is a former Established Investigator of the American Heart
Association and a National Institutes of Health Fogarty Senior International
Fellow.
|
Robert
B. Harris, Ph.D. President & CEO
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three
other partners, Dr. Harris has served as the President and as a Director
of the Company. Until 1997, Dr. Harris was employed in the Department
of Biochemistry and Molecular Biophysics at Virginia Commonwealth
University, rising through the academic ranks to full Professor. Dr.
Harris received a joint Bachelor's degree in Chemistry and Biology
from the University of Rochester, Rochester, NY, and the Master's
and Doctoral degrees from New York University, in Biochemistry and
Biophysical Chemistry. Dr. Harris is the co-author of more than 75
peer reviewed journal articles and book chapters, mostly in areas
of his research expertise: the role of macromolecular structure in
biological function. Dr. Harris is a former Established Investigator
of the American Heart Association, and is co-inventor of US and PCT
patents. |
Thomas R. Reynolds, B.S. Executive Vice President, Science & Technology and Secretary
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners, Mr. Reynolds has served as Vice President, Senior Vice President and Executive Vice President as well as a Director of the Company. Mr. Reynolds became Secretary of the Board of Directors in 1998. Mr. Reynolds is responsible for oversight of all DNA related technologies and services including management oversight of the Fairfax Identity Laboratory division. From 1987 until 1997, Mr. Reynolds served as Manager of the Nucleic Acids Core Laboratory at The Massey Cancer Center in the Department of Microbiology Biology and Immunology at Virginia Commonwealth University. From 1984 through 1986, Reynolds served as a research assistant in Genetics at Carnegie Mellon University. Mr. Reynolds is a co-inventor of several US patents, and co-author of more than 35 peer reviewed journal articles and book chapters, in the research area of molecular genetics. |
James
H. Brennan, M.B.A.
Mr. Brennan joined the Company in December, 1997, and assumed the
duties of Controller. Brennan is an Officer of the Company. From 1988-
1997, Brennan served as the Chief Financial Officer or Controller
of different companies in and around the Richmond Area, including
Star Tobacco and Pharmaceuticals, Delta Airport Consultants, Herald
Pharmaceuticals, and the Christian Childrens' Fund. |
 |
Commonwealth
Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 (800-RELY-CBI) FAX: 804-648-2641
email: [email protected] |
|
|